SCHOLAR ROCK HOLDING CORPORATION Weighted Average Number of Shares Outstanding, Basic and Diluted
SCHOLAR ROCK HOLDING CORPORATION (SRRK) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 36.58 million shares for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-08-10
- SCHOLAR ROCK HOLDING CORPORATION weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 36.58M shares, a 23.21% increase year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 36.38M shares, a 23.21% increase year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 33.94M shares, a 15.58% increase year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 29.78M shares, a 1.87% increase year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 30.73M shares, a 11.61% increase from fiscal 2019.
- SCHOLAR ROCK HOLDING CORPORATION weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 27.54M shares, a 75.90% increase from fiscal 2018.
- SCHOLAR ROCK HOLDING CORPORATION weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 15.66M shares, a 858.04% increase from fiscal 2017.
- SCHOLAR ROCK HOLDING CORPORATION weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 1.63M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-06-30 | 36.58M shares 10-Q · filed 2021-08-10 | 36.48M shares 10-Q · filed 2021-08-10 | 35.63M shares derived: average of 3 quarters · filed 2021-08-10 | 34.17M shares derived: average of 4 quarters · filed 2021-08-10 |
| 2021-03-31 | 36.38M shares 10-Q · filed 2021-05-13 | 35.16M shares derived: average of 2 quarters · filed 2021-05-13 | 33.37M shares derived: average of 3 quarters · filed 2021-05-13 | 32.45M shares derived: average of 4 quarters · filed 2021-08-10 |
| 2020-12-31 | 33.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | 31.86M shares derived: average of 2 quarters · filed 2021-03-09 | 31.14M shares derived: average of 3 quarters · filed 2021-08-10 | 30.73M shares 10-K · filed 2021-03-09 |
| 2020-09-30 | 29.78M shares 10-Q · filed 2020-11-09 | 29.73M shares derived: average of 2 quarters · filed 2021-08-10 | 29.67M shares 10-Q · filed 2020-11-09 | 29.59M shares derived: average of 4 quarters · filed 2021-08-10 |
| 2020-06-30 | 29.69M shares 10-Q · filed 2021-08-10 | 29.61M shares 10-Q · filed 2021-08-10 | 29.53M shares derived: average of 3 quarters · filed 2021-08-10 | 29.45M shares derived: average of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | 29.53M shares 10-Q · filed 2021-05-13 | 29.45M shares derived: average of 2 quarters · filed 2021-05-13 | 29.37M shares derived: average of 3 quarters · filed 2021-05-13 | 28.51M shares derived: average of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | 29.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | 29.30M shares derived: average of 2 quarters · filed 2021-03-09 | 28.17M shares derived: average of 3 quarters · filed 2021-03-09 | 27.54M shares 10-K · filed 2021-03-09 |
| 2019-09-30 | 29.23M shares 10-Q · filed 2020-11-09 | 27.58M shares derived: average of 2 quarters · filed 2020-11-09 | 26.93M shares 10-Q · filed 2020-11-09 | 26.36M shares derived: average of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | 25.92M shares 10-Q · filed 2020-08-07 | 25.76M shares 10-Q · filed 2020-08-07 | 25.40M shares derived: average of 3 quarters · filed 2020-08-07 | 25.13M shares derived: average of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | 25.59M shares 10-Q · filed 2020-05-07 | 25.14M shares derived: average of 2 quarters · filed 2020-05-07 | 24.86M shares derived: average of 3 quarters · filed 2020-05-07 | 21.29M shares derived: average of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | 24.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 24.50M shares derived: average of 2 quarters · filed 2020-03-12 | 19.86M shares derived: average of 3 quarters · filed 2020-03-12 | 15.66M shares 10-K · filed 2020-03-12 |
| 2018-09-30 | 24.31M shares 10-Q · filed 2019-11-12 | 17.45M shares derived: average of 2 quarters · filed 2019-11-12 | 12.65M shares 10-Q · filed 2019-11-12 | |
| 2018-06-30 | 10.59M shares 10-Q · filed 2019-08-14 | 6.72M shares 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | 2.80M shares 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | 1.63M shares 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |